Genome-Wide CRISPR/Cas9 Screening Identifies That Mitochondrial Solute Carrier SLC25A23 Attenuates Type I IFN Antiviral Immunity via Interfering with MAVS Aggregation
The Journal of Immunology · 2023
DOI: 10.4049/jimmunol.2300187 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2023. Verfasst von Hongguang Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Interferon Type I, Adaptor Proteins, Signal Transducing, RNA Virus Infections, Mitochondrial Membrane Transport Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: The National Natural Science Foundation of China.
Abstract (Originalsprache)
Activation of the mitochondrial antiviral signaling (MAVS) adaptor, also known as IPS-1, VISA, or Cardif, is crucial for antiviral immunity in retinoic acid–inducible gene I (RIG-I)–like receptor signaling. Upon interacting with RIG-I, MAVS undergoes K63-linked polyubiquitination by the E3 ligase Trim31, and subsequently aggregates to activate downstream signaling effectors. However, the molecular mechanisms that modulate MAVS activation are not yet fully understood. In this study, the mitochondrial solute carrier SLC25A23 was found to attenuate type I IFN antiviral immunity using genome-wide CRISPR/Cas9 screening. SLC25A23 interacts with Trim31, interfering with its binding of Trim31 to MAVS. Indeed, SLC25A23 downregulation was found to increase K63-linked polyubiquitination and subsequent aggregation of MAVS, which promoted type I IFN production upon RNA virus infection. Consistently, mice with SLC25A23 knockdown were more resistant to RNA virus infection in vivo. These findings establish SLC25A23 as a novel regulator of MAVS posttranslational modifications and of type I antiviral immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China.
- Department of Reproductive Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China.
- Department of Genetics and Cell Biology, Basic Medical College, Qingdao University, Qingdao, China.
ORCID-Profile: Zheng Wang, Sidong Xiong
Förderung
- The National Natural Science Foundation of China
Zitieren
APA
Zhang, H., Li, X., Wang, Y., Liu, X., Guo, J., Wang, Z., Zhang, L., Xiong, S., & Dong, C. (2023). Genome-Wide CRISPR/Cas9 Screening Identifies That Mitochondrial Solute Carrier SLC25A23 Attenuates Type I IFN Antiviral Immunity via Interfering with MAVS Aggregation. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2300187
Vancouver
Zhang H, Li X, Wang Y, Liu X, Guo J, Wang Z, et al. Genome-Wide CRISPR/Cas9 Screening Identifies That Mitochondrial Solute Carrier SLC25A23 Attenuates Type I IFN Antiviral Immunity via Interfering with MAVS Aggregation. The Journal of Immunology. 2023. doi:10.4049/jimmunol.2300187
BibTeX
@article{Zhang2023,
author = {Zhang, Hongguang and Li, Xin and Wang, Yiwei and Liu, Xianxian and Guo, Jing and Wang, Zheng and Zhang, Lulu and Xiong, Sidong and Dong, Chunsheng},
title = {Genome-Wide CRISPR/Cas9 Screening Identifies That Mitochondrial Solute Carrier SLC25A23 Attenuates Type I IFN Antiviral Immunity via Interfering with MAVS Aggregation},
journal = {The Journal of Immunology},
year = {2023},
doi = {10.4049/jimmunol.2300187}
}
EUVIMED